Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-003202
Filing Date
2019-02-11
Accepted
2019-02-11 19:18:29
Documents
2
Period of Report
2019-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9684
2 EX-24 DOCUMENT attachment1.htm EX-24 3968
  Complete submission text file 0000899243-19-003202.txt   15087
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SERES THERAPEUTICS, INC. 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Henn Matthew R. (Reporting) CIK: 0001767321 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 19587155